Browsing by Author Liberopoulos, E. N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 58 to 77 of 117 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patientsNakou, E.; Filippatos, T. D.; Liberopoulos, E. N.; Tselepis, A. D.; Kiortsis, D. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Effects of thyroid dysfunction on lipid profileRizos, C. V.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
Efficacy and safety of ezetimibe plus orlistat or rimonabant in statin-intolerant nondiabetic overweight/obese patients with dyslipidemiaFlorentin, M.; Kostapanos, M. S.; Nakou, E. S.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
Electrolyte disturbances in patients with hyponatremiaLiamis, G.; Mitrogianni, Z.; Liberopoulos, E. N.; Tsimihodimos, V.; Elisaf, M. S.24-Nov-2015-
Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?Tsouli, S. G.; Liberopoulos, E. N.; Mikhailidis, D. P.; Athyros, V. G.; Elisaf, M. S.24-Nov-2015-
Emerging options in the treatment of dyslipidemias: a bright future?Florentin, M.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Exacerbation of tuberculosis enteritis after treatment with infliximabLiberopoulos, E. N.; Drosos, A. A.; Elisaf, M. S.24-Nov-2015-
Ezetimibe Treatment Lowers Indicators of Oxidative Stress in Hypercholesterolemic Subjects with High Oxidative StressKostapanos, M. S.; Spyrou, A. T.; Tellis, C. C.; Gazi, I. F.; Tselepis, A. D.; Elisaf, M.; Liberopoulos, E. N.24-Nov-2015-
Ezetimibe-associated adverse effects: what the clinician needs to knowFlorentin, M.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Fenofibrate in primary biliary cirrhosis: a pilot studyLiberopoulos, E. N.; Florentin, M.; Elisaf, M. S.; Mikhailidis, D. P.; Tsianos, E.24-Nov-2015-
Fibrate-associated adverse effects beyond muscle and liver toxicityFlorentin, M.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Fibrinogen: a predictor of vascular diseaseKakafika, A. I.; Liberopoulos, E. N.; Mikhailidis, D. P.24-Nov-2015-
Greece: one of the thirty top-performing countries in all scientific fields?Liberopoulos, E. N.; Mikhailidis, D. P.24-Nov-2015-
How safe is the use of thiazolidinediones in clinical practice?Rizos, C. V.; Elisaf, M. S.; Mikhailidis, D. P.; Liberopoulos, E. N.24-Nov-2015-
The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterolGazi, I. F.; Filippatos, T. D.; Tsimihodimos, V.; Saougos, V. G.; Liberopoulos, E. N.; Mikhailidis, D. P.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
HypocholesterolemiaMoutzouri, E.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failureMilionis, H. J.; Alexandrides, G.; Liberopoulos, E. N.; Bairaktari, E. T.; Goudevenos, J.; Elisaf, M. S.24-Nov-2015-
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levelsAthyros, V. G.; Mikhailidis, D. P.; Kakafika, A. I.; Karagiannis, A.; Hatzitolios, A.; Tziomalos, K.; Ganotakis, E. S.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Influence of apolipoprotein E polymorphisms on serum creatinine levels and predicted glomerular filtration rate in healthy subjectsLiberopoulos, E. N.; Miltiadous, G. A.; Cariolou, M.; Kalaitzidis, R.; Siamopoulos, K. C.; Elisaf, M. S.24-Nov-2015-
The influence of serum apolipoprotein E concentration and polymorphism on serum lipid parameters in hemodialysis patientsLiberopoulos, E. N.; Miltiadous, G. A.; Cariolou, M.; Tselepis, A. D.; Siamopoulos, K. C.; Elisaf, M. S.24-Nov-2015-